AE10236
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1mg | in stock | $19.00 | $14.00 | - + | ||
5mg | in stock | $39.00 | $28.00 | - + | ||
10mg | in stock | $55.00 | $38.00 | - + | ||
50mg | in stock | $157.00 | $110.00 | - + | ||
100mg | in stock | $266.00 | $187.00 | - + | ||
250mg | in stock | $451.00 | $316.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AE10236 |
Chemical Name: | Epimedin C |
CAS Number: | 110642-44-9 |
Molecular Formula: | C39H50O19 |
Molecular Weight: | 822.8029 |
MDL Number: | MFCD04039820 |
SMILES: | COc1ccc(cc1)c1oc2c(CC=C(C)C)c(O[C@@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O)cc(c2c(=O)c1O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O)O)O)O |
Complexity: | 1450 |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 15 |
Heavy Atom Count: | 58 |
Hydrogen Bond Acceptor Count: | 19 |
Hydrogen Bond Donor Count: | 10 |
Rotatable Bond Count: | 11 |
XLogP3: | 0.6 |
Epimedin C, a compound extracted from the traditional Chinese herb Epimedium, is a valuable molecule in chemical synthesis. Its unique structure and properties make it a versatile building block in the creation of various pharmaceuticals, natural products, and fine chemicals. Epimedin C has been found to exhibit promising biological activities, making it a popular choice for medicinal chemistry research.In chemical synthesis, Epimedin C serves as a key intermediate in the production of potent anti-cancer drugs, cardiovascular medications, and anti-inflammatory agents. Its strategic placement in synthetic pathways allows for the efficient construction of complex molecular architectures with high precision and control. Epimedin C's functional groups and stereochemistry contribute to its ability to participate in diverse chemical reactions, enabling the synthesis of highly specific and biologically active compounds.Furthermore, the incorporation of Epimedin C in chemical synthesis not only enhances the efficiency of drug discovery and development processes but also opens up new possibilities for designing novel therapeutic agents with improved efficacy and safety profiles. Its structural features offer researchers a valuable platform for molecular modifications and structure-activity relationship studies, leading to the creation of potent drug candidates with enhanced biological activities and reduced side effects.Overall, the application of Epimedin C in chemical synthesis underscores its significance as a valuable tool for the design and production of pharmaceuticals and bioactive compounds with therapeutic potential and broad applicability in the healthcare industry.
Yao xue xue bao = Acta pharmaceutica Sinica 20120401
Bioscience, biotechnology, and biochemistry 20120101
Journal of separation science 20111101
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20111001
Se pu = Chinese journal of chromatography 20110901
Molecular bioSystems 20110701
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20101201
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20090401
Journal of chromatographic science 20090101
Pharmaceutical research 20080901
Ultrasonics sonochemistry 20080401
Phytochemical analysis : PCA 20080101
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20071101
Journal of chromatography. A 20070907
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20070901
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050725
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20050401
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20031101
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20030401